11.30
price down icon0.89%   -0.125
 
loading

Replimune Group Inc Stock (REPL) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
3.92%
58.76
56.54 63.83 55.65 52.99
Operating Income/Loss
3.92%
-58.76
-56.54 -63.83 -55.65 -52.99
Nonoperating Income/Loss
38.64%
3.616
5.893 3.586 6.294 4.044
Income/Loss From Continuing Operations Before Tax
8.87%
-55.14
-50.65 -60.24 -49.35 -48.95
Income Tax Expense/Benefit
113.74%
-0.065
0.473 -0.201 0.201 -
Income/Loss From Continuing Operations After Tax
6.94%
-54.67
-51.12 -60.04 -49.55 -48.95
Net Income/Loss
7.74%
-55.08
-51.12 -60.04 -49.55 -49.24
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.94%
0.0374
66.65 66.58 66.37 2.595
Diluted Average Shares
99.94%
0.0374
66.65 66.58 66.37 2.595
Basic Earnings Per Share
6.49%
-0.82
-0.77 -0.90 -0.75 -0.74
Diluted Earnings Per Share
6.49%
-0.82
-0.77 -0.90 -0.75 -0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.87
price down icon 0.16%
$312.36
price up icon 1.23%
$33.28
price down icon 0.12%
$19.66
price up icon 0.30%
$99.02
price down icon 0.04%
biotechnology ONC
$262.30
price down icon 0.18%
Cap:     |  Volume (24h):